• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants.注射器交换项目参与者中非法使用丁丙诺啡的情况、对丁丙诺啡治疗的兴趣及获取途径。
J Subst Abuse Treat. 2015 Jan;48(1):112-6. doi: 10.1016/j.jsat.2014.07.015. Epub 2014 Aug 7.
2
Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.纽约市一个针头交换项目中阿片类药物使用者对丁丙诺啡的知晓度、使用体验及态度。
J Opioid Manag. 2013 Nov-Dec;9(6):407-13. doi: 10.5055/jom.2013.0183.
3
HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.乌克兰为注射吸毒者提供丁丙诺啡阿片类药物替代疗法的艾滋病毒治疗获取与扩大——项目描述及政策影响
Int J Drug Policy. 2007 Aug;18(4):326-8. doi: 10.1016/j.drugpo.2006.12.011. Epub 2007 Feb 5.
4
Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.减少伤害机构作为丁丙诺啡治疗的潜在场所。
Subst Abus. 2015;36(2):155-60. doi: 10.1080/08897077.2015.1011820.
5
Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.家庭医生采用丁丙诺啡维持疗法的障碍分析。
Rural Remote Health. 2015;15:3019. Epub 2015 Feb 4.
6
Consumer attitudes about opioid addiction treatment: a focus group study in New York City.消费者对阿片类药物成瘾治疗的态度:纽约市的一项焦点小组研究。
J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.
7
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.从监禁中获释、复吸阿片类药物以及丁丙诺啡维持治疗的可能性:对患有阿片类药物使用障碍的前囚犯认知的定性研究
Addict Sci Clin Pract. 2015 Jan 16;10(1):2. doi: 10.1186/s13722-014-0023-0.
8
Use and misuse of opioid replacement therapies: a Queensland study.阿片类药物替代疗法的使用和滥用:昆士兰研究。
Subst Use Misuse. 2012 Jan;47(1):78-85. doi: 10.3109/10826084.2011.629017.
9
Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine/naloxone in marginalized populations.阿片类药物维持治疗作为纽约市阿片类药物依赖者的减少伤害工具:有必要扩大在边缘化人群中使用丁丙诺啡/纳洛酮的机会。
J Addict Dis. 2012;31(3):278-87. doi: 10.1080/10550887.2012.694603.
10
Buprenorphine in the United States: Motives for abuse, misuse, and diversion.丁丙诺啡在美国:滥用、误用和转移的动机。
J Subst Abuse Treat. 2019 Sep;104:148-157. doi: 10.1016/j.jsat.2019.07.005. Epub 2019 Jul 12.

引用本文的文献

1
Interest in contingency management and reducing stimulant use among syringe service program participants.对注射器服务项目参与者进行应急管理及减少兴奋剂使用的关注。
J Subst Use Addict Treat. 2025 Jul 31:209763. doi: 10.1016/j.josat.2025.209763.
2
Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: results from a national survey.美国警察局长对物质使用障碍、芬太尼暴露、过量用药应对及自由裁量权使用的看法:一项全国性调查结果
Health Justice. 2025 Mar 5;13(1):13. doi: 10.1186/s40352-025-00318-8.
3
Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study.评估非医疗用途阿片类药物使用者对药物配方和治疗模式的偏好:一项基于网络的横断面研究。
J Subst Use Addict Treat. 2024 Aug;163:209383. doi: 10.1016/j.josat.2024.209383. Epub 2024 Apr 24.
4
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.30 年来针对注射毒品者的美沙酮维持治疗方案参与者的物质使用障碍治疗研究:文献综述。
Addict Sci Clin Pract. 2023 Jun 10;18(1):40. doi: 10.1186/s13722-023-00394-x.
5
Patient-reported problems filling buprenorphine prescriptions and motivations for illicit use.患者报告的丁丙诺啡处方配药问题及非法使用动机。
Drug Alcohol Depend Rep. 2022 Sep 8;5:100091. doi: 10.1016/j.dadr.2022.100091. eCollection 2022 Dec.
6
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation.基于远程医疗的 HIV 暴露前预防和丁丙诺啡/纳洛酮方案在注射服务项目中的可接受性和可行性:一项定性描述性评估。
Harm Reduct J. 2022 Dec 3;19(1):132. doi: 10.1186/s12954-022-00718-1.
7
'It's the same thing as giving them CPR training': rural first responders' perspectives on naloxone.“这和给他们做心肺复苏培训是一回事”:农村急救人员对纳洛酮的看法。
Harm Reduct J. 2022 Oct 3;19(1):111. doi: 10.1186/s12954-022-00688-4.
8
Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs.在注射服务项目中建模成本效益以及对致命过量和丁丙诺啡-纳洛酮治疗开始的影响。
Addiction. 2022 Oct;117(10):2635-2648. doi: 10.1111/add.15883. Epub 2022 Apr 3.
9
Low-threshold Buprenorphine Treatment in a Syringe Services Program: Program Description and Outcomes.在注射服务项目中实施低门槛丁丙诺啡治疗:项目描述与结果。
J Addict Med. 2022;16(4):447-453. doi: 10.1097/ADM.0000000000000934. Epub 2021 Nov 12.
10
Strategies to improve implementation of medications for opioid use disorder reported by veterans involved in the legal system: A qualitative study.提高法律体系内退伍军人阿片类药物使用障碍药物治疗实施率的策略:一项定性研究。
J Subst Abuse Treat. 2021 Oct;129:108353. doi: 10.1016/j.jsat.2021.108353. Epub 2021 Mar 4.

本文引用的文献

1
I heard about it from a friend: assessing interest in buprenorphine treatment.我从一个朋友那里听说了这件事:评估对丁丙诺啡治疗的兴趣。
Subst Abus. 2014;35(1):74-9. doi: 10.1080/08897077.2013.804484.
2
Determinants of buprenorphine treatment for opioid dependence.丁丙诺啡治疗阿片类物质依赖的决定因素。
J Subst Abuse Treat. 2014 Mar;46(3):315-9. doi: 10.1016/j.jsat.2013.09.003. Epub 2013 Oct 25.
3
Clinician beliefs and attitudes about buprenorphine/naloxone diversion.临床医生对丁丙诺啡/纳洛酮转用的看法和态度。
Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x. Epub 2013 Apr 11.
4
Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.巴尔的摩市当前和既往注射吸毒者街头获取丁丙诺啡使用的流行情况及其相关因素。
Addict Behav. 2013 Dec;38(12):2868-73. doi: 10.1016/j.addbeh.2013.08.008. Epub 2013 Aug 17.
5
Responses of state Medicaid programs to buprenorphine diversion: doing more harm than good?州医疗补助计划对丁丙诺啡转移的应对措施:是否弊大于利?
JAMA Intern Med. 2013 Sep 23;173(17):1571-2. doi: 10.1001/jamainternmed.2013.9059.
6
Vital signs: overdoses of prescription opioid pain relievers and other drugs among women--United States, 1999-2010.生命体征:1999-2010 年美国女性处方类阿片类止痛药和其他药物过量情况。
MMWR Morb Mortal Wkly Rep. 2013 Jul 5;62(26):537-42.
7
Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes.先前使用丁丙诺啡的经历与门诊丁丙诺啡治疗结果相关。
J Addict Med. 2013 Jul-Aug;7(4):287-93. doi: 10.1097/ADM.0b013e31829727b2.
8
Consumer attitudes about opioid addiction treatment: a focus group study in New York City.消费者对阿片类药物成瘾治疗的态度:纽约市的一项焦点小组研究。
J Opioid Manag. 2013 Mar-Apr;9(2):111-9. doi: 10.5055/jom.2013.0152.
9
Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes.苯二氮䓬类药物在丁丙诺啡治疗阿片类药物依赖中的使用:临床和安全性结果。
Drug Alcohol Depend. 2013 Oct 1;132(3):580-6. doi: 10.1016/j.drugalcdep.2013.04.006. Epub 2013 May 18.
10
Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems.进入以基层医疗为基础的丁丙诺啡治疗与识别和治疗其他慢性医学问题有关。
Addict Sci Clin Pract. 2012 Oct 29;7(1):22. doi: 10.1186/1940-0640-7-22.

注射器交换项目参与者中非法使用丁丙诺啡的情况、对丁丙诺啡治疗的兴趣及获取途径。

Illicit buprenorphine use, interest in and access to buprenorphine treatment among syringe exchange participants.

作者信息

Fox Aaron D, Chamberlain Adam, Sohler Nancy L, Frost Taeko, Cunningham Chinazo O

机构信息

Albert Einstein College of Medicine, Bronx, NY 10461, USA; Montefiore Medical Center, Bronx, NY 10467, USA.

Albert Einstein College of Medicine, Bronx, NY 10461, USA.

出版信息

J Subst Abuse Treat. 2015 Jan;48(1):112-6. doi: 10.1016/j.jsat.2014.07.015. Epub 2014 Aug 7.

DOI:10.1016/j.jsat.2014.07.015
PMID:25205666
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4250323/
Abstract

Poor access to buprenorphine maintenance treatment (BMT) may contribute to illicit buprenorphine use. This study investigated illicit buprenorphine use and barriers to BMT among syringe exchange participants. Computer-based interviews conducted at a New York City harm reduction agency determined: prior buprenorphine use; barriers to BMT; and interest in BMT. Of 102 opioid users, 57 had used illicit buprenorphine and 32 had used prescribed buprenorphine. When illicit buprenorphine users were compared to non-users: barriers to BMT ("did not know where to get treatment") were more common (64 vs. 36%, p<0.01); mean levels of interest in BMT were greater (3.37 ± 1.29 vs. 2.80 ± 1.34, p=0.03); and more participants reported themselves likely to initiate treatment (82 vs. 50%, p<0.01). Illicit buprenorphine users were interested in BMT but did not know where to go for treatment. Addressing barriers to BMT could reduce illicit buprenorphine use.

摘要

丁丙诺啡维持治疗(BMT)的可及性差可能会导致丁丙诺啡的非法使用。本研究调查了注射器交换项目参与者中丁丙诺啡的非法使用情况以及接受BMT的障碍。在纽约市一家减少伤害机构进行的基于计算机的访谈确定了:既往丁丙诺啡使用情况;接受BMT的障碍;以及对BMT的兴趣。在102名阿片类药物使用者中,57人曾使用过非法丁丙诺啡,32人曾使用过处方丁丙诺啡。将非法丁丙诺啡使用者与非使用者进行比较时发现:接受BMT的障碍(“不知道何处接受治疗”)更为常见(64%对36%,p<0.01);对BMT的平均兴趣水平更高(3.37±1.29对2.80±1.34,p=0.03);并且更多参与者表示自己可能开始治疗(82%对50%,p<0.01)。非法丁丙诺啡使用者对BMT感兴趣,但不知道去哪里接受治疗。解决接受BMT的障碍可能会减少丁丙诺啡的非法使用。